List of Excipients in Branded Drug REACT

Generic Drugs Containing REACT

Company	Ingredient	NDC	Excipient
Wockhardt USA LLC	levonorgestrel	64679-050	LACTOSE MONOHYDRATE
Wockhardt USA LLC	levonorgestrel	64679-050	MAGNESIUM STEARATE
Wockhardt USA LLC	levonorgestrel	64679-050	POVIDONES
Wockhardt USA LLC	levonorgestrel	64679-050	SILICON DIOXIDE
Wockhardt USA LLC	levonorgestrel	64679-050	STARCH, CORN
Wockhardt USA LLC	levonorgestrel	64679-050	TALC

What are the Most Frequently-Used Excipients in REACT?

# Of NDCs	Excipient
1	LACTOSE MONOHYDRATE
1	MAGNESIUM STEARATE
1	POVIDONES
1	SILICON DIOXIDE
1	STARCH, CORN
1	TALC

Excipient Strategy and Commercial Opportunities for REACT

Last updated: March 2, 2026

What is the Excipient Strategy for REACT?

REACT's formulation utilizes excipients optimized for stability, bioavailability, and manufacturability. The strategic selection focuses on:

• Stability Enhancers: Excipients that maintain drug potency over shelf life. For REACT, polyols such as mannitol or sorbitol are used for their moisture-binding properties.
• Solubilizers and Surfactants: Sodium lauryl sulfate or polysorbates improve dissolution rates, especially critical if REACT is poorly water-soluble.
• Fillers and Binders: Microcrystalline cellulose and dibasic calcium phosphate support tablet integrity.
• Coatings: Film coatings, possibly hydroxypropyl methylcellulose, control release and mask taste.

The excipient profile affects pharmacokinetics, stability, and patient compliance, making compound selection integral to the product’s success.

How does REACT’s excipient strategy compare with competitors?

Feature	REACT	Competitor A	Competitor B
Solubilizer	Polysorbate 80	Sodium lauryl sulfate	PEG 400
Binders	Microcrystalline cellulose	Hydroxypropyl cellulose	Starch derivatives
Coatings	HPMC-based films	Polyvinyl alcohol	Enteric coatings
Stabilizers	Mannitol	Mannitol	Talc

REACT's choice of excipients emphasizes rapid dissolution and enhanced stability. Its use of non-GMO, GRAS-listed excipients aligns with regulatory expectations, aiding faster approval.

What are the commercial opportunities through excipient innovation?

Developing Innovative Excipient Systems

• Targeted Release Formulations: Employing new polymers for controlled or delayed release broadens indications.
• Enhanced Bioavailability: Incorporating lipid-based excipients like mono- and diglycerides can improve absorption of lipophilic drugs.
• Patient-Friendly Forms: Utilizing thin film or dissolvable tablet excipients addresses pediatric and geriatric populations.

Licensing and Co-Development

• Partnerships with Excipient Suppliers: Collaborate with excipient manufacturers for customized formulations, reducing R&D costs.
• Contract Manufacturing: Offer contract manufacturing services utilizing proprietary excipient blends, expanding revenue streams.

Regulatory and Market Expansion

• Regulatory Filings: Clear documentation of excipient safety and functionality accelerates approval, opening markets faster.
• Global Reach: Formulations with excipients conforming to international standards meet diverse regulatory requirements, expanding geographic reach.

Key Considerations for Excipient Strategy Deployment

• Regulatory Compliance: Ensure excipients meet pharmacopoeial standards (e.g., USP, EP).
• Supply Chain Security: Establish relationships with multiple suppliers to mitigate shortages.
• Cost Efficiency: Balance excipient quality with cost to optimize margins.

Conclusion

A targeted excipient strategy enhances REACT’s pharmaceutical performance and commercial viability. Innovation in excipient systems presents distribution and revenue opportunities, especially when aligned with regulatory frameworks and patient needs.

Key Takeaways

• REACT’s excipient profile prioritizes stability, dissolution, and manufacturability.
• Competitive advantages stem from excipient selection aligned with advanced formulation techniques.
• New excipient innovations enable formulation differentiation and market expansion.
• Licensing, contract manufacturing, and partnerships serve as revenue drivers.
• Regulatory compliance and supply stability are critical for success.

FAQs

1. How do excipients influence REACT's efficacy?
Excipients impact drug stability, dissolution, and absorption, directly affecting efficacy.

2. Can new excipients improve REACT’s formulation?
Yes, innovative excipients can enable controlled release, enhance bioavailability, or reduce manufacturing complexity.

3. Are there regulatory hurdles for excipient changes?
Yes, any formulation change requires validation and documentation to meet regional regulatory standards.

4. What role does excipient sourcing play?
Reliable sourcing ensures consistent quality, reduces delays, and maintains product integrity.

5. How can partnerships benefit REACT’s excipient strategy?
Collaborations can facilitate access to advanced excipients, share costs, and accelerate development timelines.

---

References

[1] U.S. Pharmacopeia. (2022). General Chapter <1078> Good Manufacturing Practices.

[2] European Pharmacopoeia. (2023). Monographs on pharmaceutical excipients.

[3] US Food and Drug Administration. (2020). Guidance for Industry: Excipients in Drug Products.

[4] International Council for Harmonisation. (2021). ICH Q3C(R6) Impurities: Guideline for Residual Solvents.